biotech
Using Proteomics To Detect Cancer in Dogs
Filed in archive Diagnostics, Methodologies and Instrumentation , Genomics, Proteomics and Bioinformatics by ruth on November 23, 2006
Using Proteomics To Detect Cancer in Dogs
British biotech company, PetScreen Limited has developed an innovative screening and treatment optimisation programme for canine lymphoma, which accoutns for 20% of cancers in high-risk breeds. This is the first of its kind to be made commercially available.
PetScreen has developed the screen based on proteomic technology which has emerged from the sequencing of both the human and canine genomes. It facilitates regular, routine screening which enables cancer to be detected at a much earlier stage when, as in humans, treatment has the best chance of success.

According to the Pet Screen's press release, one in four dogs develop cancer in their lifetimes and recommend that the screen be regarded as part of pet's overall wellness programme.

Well, if your pet insurance provider would cover it, why not?

Permalink: Using Proteomics To Detect Cancer in Dogs
Tags: cancer  pets  canine+cancer  lymphoma  canine+lymphoma  pet+insurance  diagnostics  biotech  using+proteomic 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/43541
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Using Proteomics To Detect Cancer in Dogs:

  • Currently 7.33/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.33 out of 3 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!